July 27-31, 2025 Toronto, Canada
Bringing Innovative Solutions to Healthcare Practitioners
Bringing Innovative Solutions to Healthcare Practitioners.
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Let’s talk about moleac with noemie & david picard
Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO.
Latest News
Advancing Alzheimer’s Care: Highlights from the 2025 Scientific Meeting in Singapore
We are delighted to share some key moments from the Scientific Meeting held in Singapore on 28 June 2025.
Highlights from the 2025 Neuro Summit in Bali: Advancing Stroke, TBI, and Alzheimer’s Care
Neuro Summit | Bali, Indonesia | 20–22 June 2025.
We are excited to share the highlights from the Neuro Summit held in Bali from 20 to 22 June 2025.
🧠 NeuroAiD™II Shows Promising Results in Spinal Cord Injury Preclinical Study
Join the ASAP Webinar on AI in Stroke – 4 July 2025
Highlights from the 2025 Neurological Disorders Scientific Summit in Athens
We are pleased to share highlights from the Neurological Disorders Scientific Summit held in Athens from 12 to 15 June 2025.
New Study Establishes Global Referral Criteria for Specialist Palliative Care in Dementia
ASAP’s 54ᵗʰ Meeting at ESOC 2025: Advancing Stroke Care Across Asia
Thank You for Joining Us at ESOC 2025 – See You Next Year!
As ESOC draws to a close, we would like to extend a heartfelt thank you to each and every attendee. Your participation truly made this event memorable.
Unlocking Recovery Potential: Highlights from Our ESOC 2025 Symposium on Post-Stroke Neurorehabilitation
Unlocking Recovery Potential: Advances in Post-Stroke Neurorehabilitation.
Happening Today at ESOC 2025: Join Our Symposium on Post-Stroke Neurorehabilitation
📢 Join us TODAY at ESOC 2025 in Helsinki. Don’t miss our symposium on Unlocking Recovery Potential: Advances in Post-Stroke Neurorehabilitation.
